Bayer Tells 2nd Circuit Mirena Experts, ‘Admissions’ Evidence Properly Excluded
NEW YORK — Bayer HealthCare Pharmaceuticals Inc. on March 8 told the Second Circuit U.S. Court of Appeals that the Mirena multidistrict litigation court did not err in excluding the plaintiffs’...To view the full article, register now.
Already a subscriber? Click here to view full article